PIA
SGYP

Phoenix Investment Adviser’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Phoenix Investment Adviser’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-15,000
Closed -$67K – 59
2017
Q2 		$67K Buy
15,000
+10,000
+200% +$41.2K 0.05% 47
2017
Q1 		$23K Buy
+5,000
New +$29K 0.02% 58

Other funds holding SGYP

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Phoenix Investment Adviser's SGYP Position: Q3 2017 in Review

Phoenix Investment Adviser sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2017, closing a stake of 15,000 shares — an estimated $67K sold.

Phoenix Investment Adviser first reported a position in SGYP in Q1 2017 and held it in 2 quarters. The position peaked at $67K in Q2 2017. 143 funds tracked by Wall St. Rank hold SGYP as of Q3 2017.

  • Phoenix Investment Adviser reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2017 after selling out during the quarter.
  • Phoenix Investment Adviser sold 15,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2017, an estimated $67K.
  • Phoenix Investment Adviser first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2017 and held it in 2 quarters.
  • Phoenix Investment Adviser's Synergy Pharmaceuticals, Inc Common Stock position peaked at $67K in Q2 2017.
  • 143 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2017.

Based on Phoenix Investment Adviser's 13F filing for Q3 2017, filed 9 Nov 2017.